TD Cowen Issues Positive Forecast for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies (NYSE:A) had its price objective boosted by equities researchers at TD Cowen from $147.00 to $155.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. TD Cowen’s target price suggests a potential upside of 14.52% from the company’s current price.

Other research analysts have also issued research reports about the company. Barclays increased their target price on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday. UBS Group decreased their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Royal Bank Of Canada began coverage on Agilent Technologies in a report on Wednesday. They issued an “outperform” rating and a $153.00 price objective on the stock. Morgan Stanley decreased their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, Wall Street Zen lowered Agilent Technologies from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Buy” and an average price target of $160.93.

Agilent Technologies Price Performance

Shares of NYSE:A traded up $19.50 during midday trading on Thursday, reaching $135.34. 2,216,560 shares of the company’s stock traded hands, compared to its average volume of 2,189,931. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a market cap of $38.25 billion, a P/E ratio of 29.67, a PEG ratio of 2.42 and a beta of 1.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The company has a fifty day simple moving average of $114.99 and a two-hundred day simple moving average of $128.79.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the firm posted $1.31 EPS. The business’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts predict that Agilent Technologies will post 5.95 EPS for the current fiscal year.

Institutional Investors Weigh In On Agilent Technologies

Hedge funds and other institutional investors have recently bought and sold shares of the company. Core Wealth Advisors LLC acquired a new stake in Agilent Technologies during the fourth quarter worth about $26,000. SHP Wealth Management acquired a new stake in Agilent Technologies during the fourth quarter worth about $26,000. Board of the Pension Protection Fund acquired a new stake in Agilent Technologies during the fourth quarter worth about $27,000. Navalign LLC acquired a new stake in Agilent Technologies during the fourth quarter worth about $27,000. Finally, Cedar Mountain Advisors LLC acquired a new stake in Agilent Technologies during the first quarter worth about $27,000.

Agilent Technologies News Summary

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Wall Street’s Q2 expectations, reporting adjusted EPS of $1.49 versus estimates around $1.41 and revenue of $1.83 billion, above forecasts, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook and also issued Q3 guidance that points to continued growth, reinforcing confidence in demand for its lab tools and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Bank of America upgraded Agilent from neutral to buy, which typically helps sentiment because it signals improved confidence in the stock’s upside. Benzinga report on Bank of America upgrade
• Positive Sentiment: RBC also initiated coverage with an outperform rating and a $153 price target, adding another bullish analyst call after earnings. Benzinga report on RBC coverage
• Neutral Sentiment: Agilent also highlighted new product launches and digital-lab tools, including OpenLab Sync and new GC systems, which support the longer-term growth story but are less likely to move the stock immediately. Agilent Introduces OpenLab Sync

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.